1 – 250 of 314
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers : A Secondary Analysis of a Randomized Clinical Trial
2024) In JAMA Neurology(
- Contribution to journal › Article
-
Mark
Plasma neurofilament light chain is increased in Niemann-Pick Type C but glial fibrillary acidic protein remains normal
(
- Contribution to journal › Article
-
Mark
Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort
2024) In Journal of Neurology(
- Contribution to journal › Article
-
Mark
Effects of time of the day at sampling on CSF and plasma levels of Alzheimer’ disease biomarkers
(
- Contribution to journal › Article
-
Mark
Plasma glial fibrillary acidic protein and tau : predictors of neurological outcome after cardiac arrest
(
- Contribution to journal › Article
-
Mark
Elevated plasma neurofilament light and glial fibrillary acidic protein in epilepsy versus nonepileptic seizures and nonepileptic disorders
2024) In Epilepsia(
- Contribution to journal › Article
-
Mark
Plasma N-terminal containing tau fragments (NTA-tau) : a biomarker of tau deposition in Alzheimer’s Disease
(
- Contribution to journal › Article
-
Mark
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis
(
- Contribution to journal › Article
-
Mark
A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings
(
- Contribution to journal › Article
-
Mark
CT-based volumetric measures obtained through deep learning : Association with biomarkers of neurodegeneration
(
- Contribution to journal › Article
-
Mark
Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid neurofilament light predicts longitudinal diagnostic change in patients with psychiatric and neurodegenerative disorders
(
- Contribution to journal › Article
-
Mark
Biomarker-based staging of Alzheimer disease : rationale and clinical applications
(
- Contribution to journal › Scientific review
-
Mark
Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disorders
(
- Contribution to journal › Article
-
Mark
Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology
(
- Contribution to journal › Article
- 2023
-
Mark
Blood biomarkers for Alzheimer’s disease in clinical practice and trials
(
- Contribution to journal › Scientific review
-
Mark
Perioperative brain injury marker concentrations in neonatal open-heart surgery : a prospective observational study
(
- Contribution to journal › Article
-
Mark
Neurofilament light chain on intensive care admission is an independent predictor of mortality in COVID-19 : a prospective multicenter study
(
- Contribution to journal › Article
-
Mark
Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the App NL−F/NL−F knock-in mouse model of Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Clinical performance and robustness evaluation of plasma amyloid-β42/40 prescreening
(
- Contribution to journal › Article
-
Mark
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Associations of CSF PDGFRβ With Aging, Blood-Brain Barrier Damage, Neuroinflammation, and Alzheimer Disease Pathologic Changes
(
- Contribution to journal › Article
-
Mark
Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance
(
- Contribution to journal › Article
-
Mark
Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads
(
- Contribution to journal › Article
-
Mark
Robustness of CSF Aβ42/40 and Aβ42/P-tau181 measured using fully automated immunoassays to detect AD-related outcomes
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction Are Altered in Parkinson's Disease and Related Disorders
(
- Contribution to journal › Article
-
Mark
Test-retest variability of plasma biomarkers in Alzheimer's disease and its effects on clinical prediction models
(
- Contribution to journal › Article
-
Mark
Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients
(
- Contribution to journal › Article
-
Mark
Plasma neurofilament light is a predictor of neurological outcome 12 h after cardiac arrest
(
- Contribution to journal › Article
-
Mark
Ultra-high field imaging, plasma markers and autopsy data uncover a specific rostral locus coeruleus vulnerability to hyperphosphorylated tau
(
- Contribution to journal › Article
-
Mark
Age-related differences in the functional topography of the locus coeruleus and their implications for cognitive and affective functions
(
- Contribution to journal › Article
-
Mark
The genetic regulation of protein expression in cerebrospinal fluid
(
- Contribution to journal › Article
-
Mark
Alzheimer Disease Blood Biomarkers in Patients with Out-of-Hospital Cardiac Arrest
(
- Contribution to journal › Article
-
Mark
Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients : A multi-cohort study
(
- Contribution to journal › Article
-
Mark
Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers
(
- Contribution to journal › Article
-
Mark
An accurate fully automated panel of plasma biomarkers for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Brain injury markers in blood predict signs of hypoxic ischaemic encephalopathy on head computed tomography after cardiac arrest
(
- Contribution to journal › Article
-
Mark
Low-density granulocytes are related to shorter pregnancy duration but not to interferon alpha protein blood levels in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease
(
- Contribution to journal › Article
- 2022
-
Mark
Amyloid-β peptide 37, 38 and 40 individually and cooperatively inhibit amyloid-β 42 aggregation
(
- Contribution to journal › Article
-
Mark
Dynamics of Selected Biomarkers in Cerebrospinal Fluid During Complex Endovascular Aortic Repair – A Pilot Study
(
- Contribution to journal › Article
-
Mark
The accuracy and robustness of plasma biomarker models for amyloid PET positivity
(
- Contribution to journal › Article
-
Mark
Axonal injury in asymptomatic individuals preceding onset of multiple sclerosis
(
- Contribution to journal › Article
-
Mark
Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer’s disease pathology
(
- Contribution to journal › Article
-
Mark
Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer’s dementia in mild cognitive impairment patients
(
- Contribution to journal › Article
-
Mark
Central nervous system monoaminergic activity in hip osteoarthritis patients with disabling pain : associations with pain severity and central sensitization
(
- Contribution to journal › Article
-
Mark
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
GFAp and tau protein as predictors of neurological outcome after out-of-hospital cardiac arrest : A post hoc analysis of the COMACARE trial
(
- Contribution to journal › Article
-
Mark
Blood-based biomarkers for Alzheimer's disease : towards clinical implementation
(
- Contribution to journal › Scientific review
-
Mark
Serum neurofilament light levels are correlated to long-term neurocognitive outcome measures after cardiac arrest
(
- Contribution to journal › Article
-
Mark
Relationship between cerebrospinal fluid neurodegeneration biomarkers and temporal brain atrophy in cognitively healthy older adults
(
- Contribution to journal › Article
-
Mark
The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer's disease : a literature review
(
- Contribution to journal › Scientific review
-
Mark
Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p-tau
(
- Contribution to journal › Article
-
Mark
Association of Cerebrovascular and Alzheimer Disease Biomarkers With Cholinergic White Matter Degeneration in Cognitively Unimpaired Individuals
(
- Contribution to journal › Article
-
Mark
Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer's disease continuum
(
- Contribution to journal › Article
-
Mark
Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives
(
- Contribution to journal › Article
-
Mark
Association Between EEG Patterns and Serum Neurofilament Light After Cardiac Arrest : A Post Hoc Analysis of the TTM Trial
(
- Contribution to journal › Article
-
Mark
Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease–related blood-based biomarkers : Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group
(
- Contribution to journal › Article
-
Mark
Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk
(
- Contribution to journal › Article
-
Mark
Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring
(
- Contribution to journal › Article
-
Mark
Biomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigators
(
- Contribution to journal › Article
-
Mark
Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings
(
- Contribution to journal › Article
- 2021
-
Mark
Alzheimer’s disease in primary care : new tools for improved and simplified diagnostics
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Extracellular fluid, cerebrospinal fluid and plasma biomarkers of axonal and neuronal injury following intracerebral hemorrhage
(
- Contribution to journal › Article
-
Mark
CSF Aβ42 and Aβ40 and their relation to brain soluble and insoluble Aβ in the 5xFAD mouse model of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid biomarkers of glial and axonal injury in cervical spondylotic myelopathy
(
- Contribution to journal › Article
-
Mark
Plasma phosphorylated tau181 and neurodegeneration in Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
(
- Contribution to journal › Article
-
Mark
Thirty years after anorexia nervosa onset, serum neurofilament light chain protein concentration indicates neuronal injury
(
- Contribution to journal › Article
-
Mark
Neuroligin-1 in brain and CSF of neurodegenerative disorders : investigation for synaptic biomarkers
(
- Contribution to journal › Article
-
Mark
Postanoxic electrographic status epilepticus and serum biomarkers of brain injury
(
- Contribution to journal › Article
-
Mark
Association between serum urate and CSF markers of Alzheimer's disease pathology in a population-based sample of 70-year-olds
(
- Contribution to journal › Article
-
Mark
Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid biomarkers of brain injury, inflammation and synaptic autoimmunity predict long-term neurocognitive outcome in herpes simplex encephalitis
(
- Contribution to journal › Article
-
Mark
Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Infection of brain pericytes underlying neuropathology of covid‐19 patients
(
- Contribution to journal › Article
-
Mark
Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Analysis of Brain Injury Biomarker Neurofilament Light and Neurodevelopmental Outcomes and Retinopathy of Prematurity among Preterm Infants
(
- Contribution to journal › Article
-
Mark
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Tau aggregation and increased neuroinflammation in athletes after sports-related concussions and in traumatic brain injury patients – A PET/MR study
(
- Contribution to journal › Article
-
Mark
Neurofilament light as an outcome predictor after cardiac arrest : a post hoc analysis of the COMACARE trial
(
- Contribution to journal › Article
-
Mark
Tau PET correlates with different Alzheimer’s disease-related features compared to CSF and plasma p-tau biomarkers
(
- Contribution to journal › Article
-
Mark
Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
(
- Contribution to journal › Article
-
Mark
Predicting neurological outcome after out-of-hospital cardiac arrest with cumulative information; development and internal validation of an artificial neural network algorithm
(
- Contribution to journal › Article
-
Mark
Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations
(
- Contribution to journal › Article
-
Mark
Serum markers of brain injury can predict good neurological outcome after out-of-hospital cardiac arrest
(
- Contribution to journal › Article
-
Mark
Sex differences in blood-based biomarkers in individuals with autosomal dominant Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Head-to-head comparison of amplified plasmonic exosome Aβ42 platform and single-molecule array immunoassay in a memory clinic cohort
(
- Contribution to journal › Article
-
Mark
Activated low-density granulocytes in peripheral and intervillous blood and neutrophil inflammation in placentas from SLE pregnancies
(
- Contribution to journal › Article
-
Mark
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau
(
- Contribution to journal › Article
-
Mark
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration : a retrospective diagnostic performance study
(
- Contribution to journal › Article
-
Mark
A multicentre validation study of the diagnostic value of plasma neurofilament light
(
- Contribution to journal › Article
- 2020
-
Mark
Models of the blood-brain barrier using iPSC-derived cells
(
- Contribution to journal › Scientific review
-
Mark
Utility of plasma neurofilament light and total tau for clinical trials in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Alzheimers sjukdom – diagnostik och behandling i dag och i framtiden
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders
(
- Contribution to journal › Article
-
Mark
Quality of life of ice hockey players after retirement due to concussions
2020) In Concussion(
- Contribution to journal › Article
-
Mark
Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Pre-analytical protocol for measuring Alzheimer's disease biomarkers in fresh CSF
(
- Contribution to journal › Article
-
Mark
Tauopathy-Associated Tau Fragment Ending at Amino Acid 224 Is Generated by Calpain-2 Cleavage
(
- Contribution to journal › Article
-
Mark
Propagation of Tau Pathology : Integrating Insights From Postmortem and In Vivo Studies
(
- Contribution to journal › Scientific review
-
Mark
CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects
(
- Contribution to journal › Article
-
Mark
Biomarker profiling beyond amyloid and tau : cerebrospinal fluid markers, hippocampal atrophy, and memory change in cognitively unimpaired older adults
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration : A translatable marker of synaptic degeneration
(
- Contribution to journal › Article
-
Mark
Plasma neurofilament light protein correlates with diffusion tensor imaging metrics in frontotemporal dementia
(
- Contribution to journal › Article
-
Mark
Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course - A joint PhD student course at University College London and University of Gothenburg
(
- Contribution to journal › Scientific review
-
Mark
Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Plasma P-tau181 in Alzheimer’s disease : relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
(
- Contribution to journal › Article
-
Mark
Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementias
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia
(
- Contribution to journal › Article
-
Mark
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
(
- Contribution to journal › Scientific review
-
Mark
Cerebrospinal fluid tau fragment correlates with tau PET : a candidate biomarker for tangle pathology
(
- Contribution to journal › Article
-
Mark
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
(
- Contribution to journal › Article
-
Mark
Relevance of biomarkers across different neurodegenerative
(
- Contribution to journal › Scientific review
-
Mark
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease : a diagnostic performance and prediction modelling study using data from four prospective cohorts
(
- Contribution to journal › Article
-
Mark
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
(
- Contribution to journal › Scientific review
-
Mark
Association between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients with Alzheimer Disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid neurofilament light is associated with survival in mitochondrial disease patients
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid concentrations of extracellular matrix proteins in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Biomarkers for tau pathology
(
- Contribution to journal › Article
-
Mark
Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease : Cross-validation study of practical algorithms
(
- Contribution to journal › Article
-
Mark
Leptin deficiency reverses high metabolic state and weight loss without affecting central pathology in the R6/2 mouse model of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Synaptic vesicle protein 2A as a potential biomarker in synaptopathies
(
- Contribution to journal › Scientific review
-
Mark
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status
(
- Contribution to journal › Article
-
Mark
Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein
(
- Contribution to journal › Article
-
Mark
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Autocatalytic amplification of Alzheimer-associated Aβ42 peptide aggregation in human cerebrospinal fluid
(
- Contribution to journal › Article
-
Mark
Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Increased Secondary Nucleation Underlies Accelerated Aggregation of the Four-Residue N-Terminally Truncated Aβ42 Species Aβ5-42
2019) In ACS Chemical Neuroscience(
- Contribution to journal › Article
-
Mark
Serum tau fragments as predictors of death or poor neurological outcome after out-of-hospital cardiac arrest
(
- Contribution to journal › Article
-
Mark
Parkinson's disease : Evolution of cognitive impairment and CSF Aβ1-42 profiles in a prospective longitudinal study
(
- Contribution to journal › Article
-
Mark
Novel tau fragments in cerebrospinal fluid : relation to tangle pathology and cognitive decline in Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals
(
- Contribution to journal › Article
-
Mark
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia : An elusive quest
(
- Contribution to journal › Article
-
Mark
Serum Neurofilament Light Chain for Prognosis of Outcome after Cardiac Arrest
(
- Contribution to journal › Article
-
Mark
The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk
(
- Contribution to journal › Article
- 2018
-
Mark
Fluid Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia
2018) p.221-252(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Neurofilament light and tau as blood biomarkers for sports-related concussion
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders
(
- Contribution to journal › Article
-
Mark
No association of salivary total tau concentration with Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Dietary intervention with an Okinawan-based Nordic diet in type 2 diabetes renders decreased interleukin-18 concentrations and increased neurofilament light concentrations in plasma
(
- Contribution to journal › Article
-
Mark
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
(
- Contribution to journal › Article
-
Mark
Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later
(
- Contribution to journal › Article
-
Mark
Update on biomarkers for amyloid pathology in Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
Barrier Properties and Transcriptome Expression in Human iPSC-Derived Models of the Blood-Brain Barrier
(
- Contribution to journal › Article
-
Mark
Apolipoprotein E genotypes and longevity across dementia disorders
(
- Contribution to journal › Article
-
Mark
Comparing 18 F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease
(
- Contribution to journal › Article
-
Mark
Human iPS-Derived Astroglia from a Stable Neural Precursor State Show Improved Functionality Compared with Conventional Astrocytic Models
(
- Contribution to journal › Article
-
Mark
High Serum Serotonin Predicts Increased Risk for Hip Fracture and Nonvertebral Osteoporotic Fractures : The MrOS Sweden Study
(
- Contribution to journal › Article
-
Mark
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression : A study of fully automated immunoassays in BioFINDER and ADNI cohorts
(
- Contribution to journal › Article
-
Mark
Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation : A 22-year follow-up study
(
- Contribution to journal › Article
-
Mark
The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis : A review
(
- Contribution to journal › Scientific review
-
Mark
Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia
(
- Contribution to journal › Article
-
Mark
Sex-specific genetic predictors of Alzheimer’s disease biomarkers
(
- Contribution to journal › Article
-
Mark
Investigating the genetic architecture of dementia with Lewy bodies : a two-stage genome-wide association study
(
- Contribution to journal › Article
-
Mark
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
(
- Contribution to journal › Article
- 2017
-
Mark
Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival
(
- Contribution to journal › Article
-
Mark
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer's disease, and neuronal injury in humans : A cohort study
(
- Contribution to journal › Article
-
Mark
Concordance between different amyloid immunoassays and Visual amyloid positron emission tomographic assessment
(
- Contribution to journal › Article
-
Mark
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
(
- Contribution to journal › Article
-
Mark
Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders
2017) In NeuroMolecular Medicine(
- Contribution to journal › Article
-
Mark
Astroglial activation and altered amyloid metabolism in human repetitive concussion
(
- Contribution to journal › Article
-
Mark
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
(
- Contribution to journal › Article
-
Mark
Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype
(
- Contribution to journal › Article
-
Mark
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Blood-based NfL : A biomarker for differential diagnosis of parkinsonian disorder
(
- Contribution to journal › Article
-
Mark
Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway
(
- Contribution to journal › Article
-
Mark
CSF/serum albumin ratio in dementias : a cross-sectional study on 1861 patients
(
- Contribution to journal › Article
-
Mark
A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Preclinical effects of APOE ϵ4 on cerebrospinal fluid Aβ42 concentrations
(
- Contribution to journal › Article
-
Mark
Serum tau and neurological outcome in cardiac arrest
(
- Contribution to journal › Article
-
Mark
Consensus guidelines for lumbar puncture in patients with neurological diseases
(
- Contribution to journal › Article
-
Mark
Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolism
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiers
(
- Contribution to journal › Article
-
Mark
Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies
(
- Contribution to journal › Article
- 2016
-
Mark
Cerebral amyloid burden and Alzheimer's disease subtypes - does localization information matter?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease.
2016) In Movement Disorders(
- Contribution to journal › Article
-
Mark
Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease.
(
- Contribution to journal › Scientific review
-
Mark
Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Total-tau and neurofilament light in CSF reflect spinal cord ischaemia after endovascular aortic repair.
(
- Contribution to journal › Article
-
Mark
Reference measurement procedure for CSF amyloid beta (Aβ)1–42 and the CSF Aβ1–42/Aβ1–40 ratio – a cross-validation study against amyloid PET
(
- Contribution to journal › Article
-
Mark
No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF
(
- Contribution to journal › Article
-
Mark
Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET.
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis.
(
- Contribution to journal › Article
-
Mark
Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression
(
- Contribution to journal › Article
-
Mark
Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease
(
- Contribution to journal › Article
-
Mark
A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia
(
- Contribution to journal › Article
-
Mark
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios : better diagnostic markers of Alzheimer disease
(
- Contribution to journal › Article
-
Mark
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Serum neurofilament light protein predicts clinical outcome in traumatic brain injury
(
- Contribution to journal › Article
-
Mark
Plasma β-amyloid in Alzheimer's disease and vascular disease
(
- Contribution to journal › Article
-
Mark
Preclinical amyloid-β and axonal degeneration pathology in delirium
(
- Contribution to journal › Article
-
Mark
Plasma tau in Alzheimer disease
(
- Contribution to journal › Article
-
Mark
Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases.
(
- Contribution to journal › Article
- 2015
-
Mark
Amyloid biomarkers in Alzheimer's disease.
(
- Contribution to journal › Scientific review
-
Mark
Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease : A prospective 9-year study
(
- Contribution to journal › Article
-
Mark
CSF biomarkers and clinical progression of Parkinson disease.
(
- Contribution to journal › Article
-
Mark
Genetic Variants of GSK3B are Associated with Biomarkers for Alzheimer's Disease and Cognitive Function.
(
- Contribution to journal › Article
-
Mark
An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics-Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Benchmarking biomarker-based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDem.
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.
(
- Contribution to journal › Article
-
Mark
Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls
(
- Contribution to journal › Article
-
Mark
Increased CSF biomarkers of angiogenesis in Parkinson disease.
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
First Administration of the Fc-Attenuated Anti-β Amyloid Antibody GSK933776 to Patients with Mild Alzheimer's Disease: A Randomized, Placebo-Controlled Study.
(
- Contribution to journal › Article
-
Mark
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.
(
- Contribution to journal › Article
-
Mark
Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study.
2015) In Alzheimer's & Dementia(
- Contribution to journal › Article
-
Mark
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
(
- Contribution to journal › Article
- 2014
-
Mark
Monitoring of β-amyloid dynamics after human traumatic brain injury
(
- Contribution to journal › Article
-
Mark
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42: A Cross-Validation Study Against Amyloid Positron Emission Tomography.
(
- Contribution to journal › Article
-
Mark
Altered cognitive performance and synaptic function in the hippocampus of mice lacking C3.
(
- Contribution to journal › Article
-
Mark
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival.
(
- Contribution to journal › Article
-
Mark
Apolipoprotein E Genotype and the Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers for Alzheimer Disease.
(
- Contribution to journal › Article
-
Mark
The cerebrospinal fluid "Alzheimer profile": Easily said, but what does it mean?
(
- Contribution to journal › Article
-
Mark
Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of Dementia with Lewy Bodies.
(
- Contribution to journal › Article
- 2013
-
Mark
Fluid biomarkers in Alzheimer's disease - current concepts
(
- Contribution to journal › Scientific review
-
Mark
Correlations of CSF tau and amyloid levels with Alzheimer pathology in neuropathologically verified dementia with Lewy bodies.
(
- Contribution to journal › Article
-
Mark
Plasma tau levels in Alzheimer's disease
(
- Contribution to journal › Letter
-
Mark
Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia
(
- Contribution to journal › Article
-
Mark
Evaluation of the Cerebrospinal Fluid Amyloid-beta(1-42)/Amyloid-beta(1-40) Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders
(
- Contribution to journal › Article
-
Mark
Evaluating Amyloid-beta Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
A beta 1-15/16 as a Potential Diagnostic Marker in Neurodegenerative Diseases
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid Brain Injury Biomarkers in Children: A Multicenter Study
(
- Contribution to journal › Article
-
Mark
Complement Gene Single Nucleotide Polymorphisms and Biomarker Endophenotypes of Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
A Selected Reaction Monitoring (SRM)-Based Method for Absolute Quantification of A beta(38), A beta(40), and A beta(42) in Cerebrospinal Fluid of Alzheimer's Disease Patients and Healthy Controls
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid Levels of Heart Fatty Acid Binding Protein are Elevated Prodromally in Alzheimer's Disease and Vascular Dementia
(
- Contribution to journal › Article
-
Mark
Microglial Markers are Elevated in the Prodromal Phase of Alzheimer's Disease and Vascular Dementia
(
- Contribution to journal › Article